Use Actual Body Weight When Calculating Renal Function For Edoxaban

March 2015

Savaysa (sa-VAYE-sah, edoxaban) will be the fourth new oral anticoagulant (NOAC)...after Pradaxa, Xarelto, and Eliquis.

It's approved for once-daily use in atrial fib and venous thromboembolism (VTE).

But edoxaban has an odd twist when used for A fib. It does NOT work as well as warfarin in patients with NORMAL kidney function.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote